# BLACK DIAMOND THERAPEUTICS I (BDTX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/BDTX/

- Reporting holders: 3
- Reported value: $37.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [DLK Investment Management, LLC](https://holderbook.com/funds/2016793-dlk-investment-management-llc/) | $34.3K | 18,200 | 0.0% | 12 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $2.3K | 1,227 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $811 | 430 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $37.4K |
| Q2 2026 | 102 | $67.7M |
| Q1 2026 | 104 | $82.5M |
| Q4 2025 | 105 | $98.6M |
| Q3 2025 | 91 | $147.4M |
| Q2 2025 | 94 | $96.1M |
| Q1 2025 | 85 | $63.2M |
| Q4 2024 | 88 | $102.7M |
| Q3 2024 | 102 | $228.7M |
| Q2 2024 | 88 | $218.6M |
| Q1 2024 | 86 | $200.8M |
| Q4 2023 | 75 | $109.7M |